However, SVF cells derived from patients with breast cancer in remission had a higher baseline expression of IL-6, IL-8, MCP-1, and IFN-γ.
CONCLUSION:
Correlation analyses of therapeutic parameters across all donors identified positive correlations for the expression of pro-inflammatory cytokines interleukin IL6, IL8, and monocyte chemoattractant protein with each other. Samples obtained from patients in remission from breast cancer showed increased selfrenewal as well as decreased differentiation potential and increased inflammatory cytokine production. These results could be relevant for determining clinical treatment strategies for patients with a previous breast cancer diagnosis. The significant donor-to-donor variability observed for the measured parameters supports the need for standardizing both the source of cells for therapeutic procedures as well as the assessments used to predict clinical outcomes. The aim of this pilot study was to determine whether N-acetylcysteine (NAC) administered at the fat graft donor site during the harvest procedure reduces oxidative stress and thus, improves graft survivability.
The study included 15 women with mean age of 31.8 years (range, 23-39 years). A 200-ml adipose tissue graft was harvested from each thigh in each study subject. The procedure of graft harvesting from one thigh, considered as the control (n=15), included infiltration with a standard tumescent fluid. During harvesting the graft from the other thigh, a tumescent fluid containing NAC (Sandoz, Holzkirchen, Germany) was used (NAC group, n=15). Plastic surgeon who conducted the procedure was blinded to the type of administered fluid. All patients were followed-up for 6-months for potential adverse events associated with administration of the modified tumescent fluid. A 65-ml adipose tissue sample from each graft was subjected to immediate and postponed biochemical analysis, flow cytometric assay and Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR). The rest of the graft was used for correction of breast asymmetry, to determine the degree of fat resorption based on the comparison of pre-and postoperative MRI findings (separate study).
During biochemical tests, the severity of oxidative stress was determined based on the levels of reactive oxygen species (ROS) and nitric oxide (NO), along with the concentration and activity of superoxide dismutase (SOD). qRT-PCR analysis included targets linked with oxidative stress (GPX-3, hsCAT, hsSOD, iNOS, HO-1), angiogenesis (VEGF, ANG-2) and adipogenesis (PPAR-γ, C/EBP β).
Normal distribution of the study variables was verified with Kolmogorov-Smirnov test. Intragroup comparisons were carried out with Wilcoxon signed-rank test. All calculations were conducted with Statistica 10 (StatSoft, Tulsa, OK, USA), with the threshold of statistical significance set at p<0.05.
Neither local nor systemic postoperative complications were observed in the study subjects during a 6-month follow-up. Concentration of SOD in the NAC group turned out to be significantly higher than in the controls, in both fresh (p=0.041) and frozen samples (p=0.004). Also SOD activity in NAC group was significantly higher, both in fresh and frozen samples (p=0.023 and p=0.003, respectively). Interestingly, no statistically significant intergroup differences were observed in terms of ROS levels. The level of NO in frozen samples from the controls was significantly higher than in NAC group (p=0.009). The only qRT-PCR target showing significant intergroup differences was iNOS (encoding inducible NO synthase), with higher transcription levels observed in the controls (p=0.027).
The results of this study imply that addition of NAC to tumescent solution may counteract oxidative stress the cells of autologous fat graft are exposed to during the harvesting procedure. This may contribute to lesser volume of the graft that undergoes resorption over time (the study is still ongoing). The lack of adverse events after the infiltration of the fat graft donor site with NAC-enriched solution suggests that this technique is safe. If addition of NAC was shown to improve the retention of the graft, this technique might become a routine adjunct method used during this type of procedures. BACKGROUND/PURPOSE: Radiofibrosis of breast tissue ultimately compromises breast tissue reconstruction by interfering with tissue viability and healing; autologous fat transfer has recently been shown to reduce radiotherapyrelated tissue injury, thought to be attributed to the presence of adipose-derived pluripotent stem cells. 1, 2 We have identified a novel gene HMMR/RHAMM, whose expression decreases adipogenesis and increases fibrosis. We have developed RHAMM peptide mimetics (NP-110) to block RHAMM signalling, and it is thought that the injection of such a peptide will promote adipogenesis and decrease fibrosis in mammary tissue in rats.
The Promotion of Adipogenesis in a Rat

METHODS:
High frequency ultrasound was used to assess volume through thickness measurements and 3D reconstruction of mammary fat pads in 20 retired breeder female rats that were non-irradiated, irradiated, treated, and not-treated with peptide NPI-110 at days 0, 7, 14, and 21. Rats were euthanized at Day 21, and mammary fat pad tissues were processed for expression of fibrotic and adipogenetic markers using real-time polymerase chain reaction and immunohistochemistry.
RESULTS:
Volume estimates of fat pad and expression of fibrotic markers such as Collagen-1, Collagen-3, and TGFß-1, and adipogenetic markers such as PPARγ, adiponectin and perilipin were ameliorated by peptide NP-110 and radiotherapy when quantified via qPCR and immunohistochemistry. NPI-110 significantly reduced skin inflammation and radiofibrosis, the latter assessed by collagen fibril deposition via picrosirius red staining, and increased mRNA expression of adipogenic markers.
CONCLUSION:
Results from this study may aid in therapies in the human patient population which decrease the significant morbidity associated with a very challenging and common clinical problem -reconstruction in previously radiated beds in general, and breast cancer specifically.
